31 – 40 of 175
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Asymmetric contributions of seed and pollen to gene dispersal in the marsh orchid Dactylorhiza umbrosa in Asia Minor
- Contribution to journal › Article
-
Mark
Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan : a group discussion study’
- Contribution to journal › Letter
-
Mark
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
- Contribution to journal › Article
-
Mark
Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium : a cross-sectional study of 351 circumcised men in Sweden
- Contribution to journal › Article
- 2020
-
Mark
Tocilizumab-induced sarcoidosis-like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon
- Contribution to journal › Letter
-
Mark
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis
- Contribution to journal › Letter
-
Mark
Subjective and Objective Characteristics of Patients Seen at a Psychodermatology Unit : One-year Experience in Malmö, Sweden
- Contribution to journal › Article
-
Mark
Validation of a questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix I
- Contribution to journal › Article
-
Mark
Oral provocation of patients allergic to sesquiterpene lactones with German chamomile tea to demonstrate possible systemic allergic dermatitis
- Contribution to journal › Article
-
Mark
TREatment of ATopic eczema (TREAT) Registry Taskforce : protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
- Contribution to journal › Article
